Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine for Perioperative Pain in Scoliosis Surgery
NCT03537612Phase 3Terminated
- Start
- Jun 2018
- Primary completion
- Apr 2022
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Clonidine Lauriad in scoliosis (4 arms). Primary endpoint: Quantitative Sensory Testing at 6 months. Started Jun 2018; status: terminated.
02
Drugs
Clonidine Lauriad
03
Conditions
scoliosis
Beyond the preview
Go deeper on NCT03537612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03537612.